Is metformin indicated as primary ovulation induction agent in women with PCOS? A systematic review and meta-analysis (Q38003834)

26 August 2017

0 references

Is metformin indicated as primary ovulation induction agent in women with PCOS? A systematic review and meta-analysis (English)

1 reference

26 August 2017

1 reference

1 reference

1 reference

4

T F Kruger

1 reference

26 August 2017

T I Siebert

1

1 reference

26 August 2017

M I Viola

series ordinal

2

1 reference

26 August 2017

D W Steyn

series ordinal

3

1 reference

26 August 2017

publication date

17 April 2012

1 reference

Gynecologic and Obstetric Investigation

26 August 2017

published in

1 reference

26 August 2017

volume

73

1 reference

26 August 2017

issue

4

1 reference

26 August 2017

page(s)

304-313

1 reference

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

26 August 2017

cites work

1 reference

Insulin resistance in nonobese patients with polycystic ovarian disease

21 January 2018

1 reference

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

21 January 2018

1 reference

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

21 January 2018

1 reference

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

21 January 2018

1 reference

Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome

21 January 2018

1 reference

Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome

21 January 2018

1 reference

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

21 January 2018

1 reference

Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature review

21 January 2018

1 reference

A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome

21 January 2018

1 reference

Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis

21 January 2018

1 reference

Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial

21 January 2018

1 reference

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

21 January 2018

1 reference

Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycystic ovary syndrome.

21 January 2018

1 reference

Evaluating the equivalence of clomiphene citrate with and without metformin in ovulation induction in PCOS patients

21 January 2018

1 reference

Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome

21 January 2018

1 reference

Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial.

21 January 2018

1 reference

PCOSMIC: a multi-centre randomized trial in women with PolyCystic Ovary Syndrome evaluating Metformin for Infertility with Clomiphene.

21 January 2018

1 reference

An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome.

21 January 2018

1 reference

Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome

21 January 2018

1 reference

The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome

21 January 2018

1 reference

The efficacy of metformin and clomiphene citrate combination compared with clomiphene citrate alone for ovulation induction in infertile patients with PCOS

21 January 2018

1 reference

Does adding metformin to clomifene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome?

21 January 2018

1 reference

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance

21 January 2018

1 reference

The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome

21 January 2018

1 reference

Metformin in polycystic ovary syndrome: systematic review and meta-analysis

21 January 2018

1 reference

Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study

21 January 2018

1 reference

Metformin treatment in patients with polycystic ovary syndrome undergoing in vitro fertilization: a prospective randomized trial

21 January 2018

1 reference

The use of metformin for women with PCOS undergoing IVF treatment.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000335253

1 reference

26 August 2017

1 reference